Clinical trial
A Randomized, Pilot Study on the Antiviral Activity and Immunological Effects of Lopinavir/Ritonavir vs. Efavirenz in Treatment-naïve HIV-Infected Patients With CD4 Cell Counts Below 100 Cells/mm3
NCT00386659 is registered in ClinicalTrials.gov with Hospital Clinic of Barcelona as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Pilot Study on the Antiviral Activity and Immunological Effects of Lopinavir/Ritonavir vs. Efavirenz in Treatment-naïve HIV-Infected Patients With CD4 Cell Counts Below 100 Cells/mm3
- Lead sponsor
- Hospital Clinic of Barcelona
- Phase
- Phase 4
- Overall status
- Terminated
- Start date
- Not reported
- Completion date
- Not reported
- Enrollment
- 60
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
hiv infection